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Abstract Lysosomal membrane permeabilization (LMP)
occurs in response to a large variety of cell death stimuli
causing release of cathepsins from the lysosomal lumen
into the cytosol where they participate in apoptosis sig-
naling. In some settings, apoptosis induction is dependent
on an early release of cathepsins, while under other cir-
cumstances LMP occurs late in the cell death process and
contributes to amplification of the death signal. The
mechanism underlying LMP is still incompletely under-
stood; however, a growing body of evidence suggests that
LMP may be governed by several distinct mechanisms that
are likely engaged in a death stimulus- and cell-type-
dependent fashion. In this review, factors contributing to
permeabilization of the lysosomal membrane including
reactive oxygen species, lysosomal membrane lipid com-
position, proteases, p53, and Bcl-2 family proteins, are
described. Potential mechanisms to safeguard lysosomal
integrity and confer resistance to lysosome-dependent cell
death are also discussed.
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Abbreviations
Ahr Aryl hydrocarbon receptor
ANT Adenine nucleotide translocator
apoE Apolipoprotein E
BH3 Bcl-2 homology 3
Hsp Heat shock protein
JNK c-Jun N-terminal kinase
LAMP Lysosome-associated membrane protein
LAPF Lysosome-associated apoptosis-inducing
protein containing the pleckstrin homology and
FYVE domains
LEDGF Lens epithelium-derived growth factor
LMP Lysosomal membrane permeabilization
PI3K Phosphatidylinositol-3-kinase
PLA2 Phospholipase A2
ROS Reactive oxygen species
siRNA Small-interfering RNA
SMase Sphingomyelinase
TNF Tumor necrosis factor
TRAIL Tumor necrosis factor-related apoptosis
inducing ligand
UV Ultraviolet
Introduction
Over the last decade, the lysosome has emerged as a sig-
nificant component of the cellular death machinery.
Lysosomes, which were first described by de Duve and
colleagues in 1955 [1], are acidic, single-membrane bound
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organelles that are present in all eukaryotic cells [2]. The
primary function of lysosomes is degradation of macro-
molecules, and for this purpose, lysosomes are filled with
more than 50 acid hydrolases, including phosphatases,
nucleases, glycosidases, proteases, peptidases, sulphatases,
and lipases [2]. Of the lysosomal hydrolases, the cathepsin
family of proteases is the best characterized. The cathep-
sins are subdivided, according to their active site amino
acids, into cysteine (cathepsins B, C, F, H, K, L, O, S, V,
W, and X), serine (cathepsins A and G), and aspartic
cathepsins (cathepsins D and E) [3].
Cell death through apoptosis is tightly controlled by
changes in protein expression, protein-protein interactions,
and various post-translational modifications, including
proteolytic cleavage and phosphorylation. For some of
these events to occur, proteins must re-localize from one
sub-cellular compartment to another to gain access to their
substrates or interacting partners. Thus, compartmentali-
zation is yet another important regulatory mechanism,
preventing accidental triggering of cell death signaling.
The most obvious example is the release of apoptogenic
factors from mitochondria, a key event in the execution of
cell death, which is regulated mainly by proteins of the
Bcl-2 family. Lysosomal hydrolytic enzymes were initially
thought to inevitably trigger necrotic cell death when
released into the cytosol [4]. However, in 1998, we dis-
covered that the aspartic protease cathepsin D was redis-
tributed from lysosomes to the cytosol upon oxidative
stress-induced apoptotic cell death [5] (Fig. 1). Cathepsin
D was the first identified lysosomal protein with apopto-
genic properties, but the subcellular location of the protein
in dying cells was not addressed in the early publications
[6, 7]. In a series of papers from Brunk and co-workers, it
was established that the extent of lysosomal damage
determines the cell fate; a limited lysosomal release results
in cell death by apoptosis, while massive lysosomal break-
down leads to necrosis [8–12].
It is now generally accepted that apoptosis is often
associated with release of cathepsins into the cytosol, and
that, in addition to cathepsin D, cysteine cathepsins B and
L are involved in apoptosis signaling [13–17]. Moreover,
lysosomal destabilization, which will subsequently be
referred to as lysosomal membrane permeabilization
(LMP), may also occur during other types of cell death,
including necroptosis and autophagic cell death [18, 19].
LMP can be triggered by a wide range of apoptotic stimuli,
including death receptor activation, endoplasmic reticulum
stress, proteasome inhibition, oxidative stress, DNA dam-
age, osmotic stress, and growth factor starvation [13–17].
In some experimental settings, lysosomal release is an early
Fig. 1 Apoptosis-associated release of lysosomal cathepsin D into
the cytosol. Visualization of cathepsin D in rat cardiomyocytes
exposed to the redox-cycling drug naphthazarin by immunofluores-
cence microscopy (a and b) or immuno-electron microscopy using
antibodies tagged with ultra-small gold particles and subsequent
silver enhancement (c and d). There is a shift from a punctate
lysosomal staining pattern in control cells (a) to a diffuse cytosolic
staining in cells exposed to naphthazarin (b). Likewise, in electron
micrographs (c), cathepsin D can be seen in lysosome-like structures
in control cells (arrows), while in cells treated with naphthazarin (d),
cathepsin D is spread throughout the cytosol (arrow heads),
bars = 30 lm (a and b) and 1 lm (c and d)
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event essential for apoptosis signaling to proceed, while
under other circumstances LMP occurs late in the cell
death process and contributes to amplification of the death
signal (Fig. 2). Cathepsin relocalization seems to be critical
for apoptogenicity, and it has been demonstrated that
microinjection of cathepsins into the cytosol is sufficient
to trigger apoptotic cell death [20–22]. Cathepsin release
may result in caspase-dependent or -independent cell death
with or without involvement of mitochondria [13, 17].
Caspases-2 and -8, phospholipase A2 (PLA2), sphingosine
kinase-1, and the Bcl-2 family proteins Bid, Bcl-2, Bcl-XL,
and Mcl-1 may all be downstream targets of cathepsins. A
detailed description of the mechanisms by which lysosomal
cathepsins propagate the apoptotic signal can be found
elsewhere [13–16].
It is still unclear whether a subset of lysosomes is par-
ticularly susceptible to apoptosis-associated LMP and thus
release all of their contents while other lysosomes release
none, or if all lysosomes within a given cell are equally
affected but release only part of their contents. There are,
however, indications that interlysosomal differences
regarding vulnerability to LMP do exist [23, 24]. For
example, large lysosomes appears to be more susceptible to
LMP than small ones [24].
The mechanism underlying LMP is still incompletely
understood. Apart from cathepsins, other hydrolases
[25–28], H? (causing acidification of the cytosol) [29],
Ca2? [30], and several of the dyes that accumulate in lyso-
somes with intact membranes, e.g., acridine orange [8],
Lucifer Yellow [10], and LysoTracker [31], can escape into
the cytosol at the onset of apoptosis. This may suggests a
nonspecific release mechanism, such as pore formation or
limited membrane damage, rather than selective transport
across the membrane, which would likely be specific for a
single group of molecules. However, it should be noted that
the release of H?, Ca2?, and lysosomotropic dyes does not
necessarily reflect a change in membrane integrity, but
could merely be due to a change in ion pump activity. It has
been suggested that apoptosis-associated lysosomal release
is size-selective, as 10- and 40-kDa FITC-dextran molecules
are released from lysosomes during staurosporine-induced
T-cell apoptosis, while 70- and 250-kDa FITC-dextran
molecules are retained [32]. Nevertheless, that upper limit of
size-selection does not apply in all death models, as release
of the 150 kDa lysosomal protein N-acetyl-b-glucosamini-
dase has been observed under other experimental conditions
[25–27]. Conceivably, LMP may be governed by several
distinct mechanisms, each with its own characteristics,
which are likely engaged in a death stimulus- and cell-type-
dependent fashion. The mechanisms that have been sug-
gested to contribute to permeabilization of the lysosomal
membrane are described in the following sections, as are
those that are thought to safeguard lysosomal integrity and
confer resistance to lysosome-dependent cell death.
Promoters of lysosomal membrane permeabilization
Viral and bacterial proteins
Apoptosis triggered by bacterial and viral infections some-
times involves LMP, and in certain contexts the participation
of cathepsins is required for apoptotic signaling to proceed
[33–38]. The human immunodeficiency virus type 1 (HIV-1)
protein Nef is one of the non-mammalian proteins that, when
entering mammalian cells, causes permeabilization of the
lysosomal membrane [36]. Overexpression of Nef elicits an
apoptotic response in CD4? T lymphocytes via disruption of
lysosomal integrity, thus, the progressive and massive
destruction of CD4? T lymphocytes characteristic of HIV-1-
related disease may in part be due to Nef-induced LMP.
Parvovirus H1 is another virus that induces cell death char-
acterized by translocation of cathepsins to the cytosol [34]. A
small amount of viral proteins were found within the lyso-
somal fraction, and it was speculated that the capsid protein
VP1, which possesses a domain displaying phospholipase
A2 (PLA2) activity, could be involved in induction of LMP.
The diphtheria toxin is one of the most interesting
examples of a bacterial protein that can permeabilize the
Lysosome
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Fig. 2 Lysosomal participation in cell death signaling. Lysosomal
membrane permeabilization (LMP), i.e., release of cathepsins from
lysosomes into the cytosol, is an important step in cell death signaling
induced by a variety of stimuli, such as death receptor activation,
radiation, and cytotoxic drugs. Several cytosolic cathepsin targets
have been described and the signaling downstream LMP involves
both caspase-dependent and -independent pathways. Engagement of
the mitochondrial pathway is a common downstream event of LMP,
but cathepsins may also cause cell death without involvement of
mitochondria
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membranes of the endolysosomal compartment. After
entering the cell via endocytosis, one of the subdomains of
the toxin inserts into the endosomal membrane and forms
pores through which the catalytic subunit of the toxin
passes into the cytosol [39–42]. In the same way, compo-
nents of the tetanus [43], botulinum [44], and anthrax [45]
toxins are believed to permeabilize the endosomal mem-
brane to gain access to the cytosol. As discussed below,
certain mammalian proteins involved in apoptosis signal-
ing share high sequence homology with these viral pro-
teins, and may well be key regulators of apoptosis-
associated LMP.
Pro-apoptotic Bcl-2 family proteins
The Bcl-2 family consists of both pro- (e.g., Bax, Bak, Bid,
Bad, Bim, Noxa, and Puma) and anti-apoptotic (e.g., Bcl-2,
Bcl-XL, and Mcl-1) proteins that are critical regulators of
the mitochondrial pathway to cell death. The multi-domain
proteins Bax and Bak are pore-forming proteins that enable
the release of apoptogenic factors such as cytochrome c
from mitochondria, while the so-called BH3-only-domain
proteins (e.g., Bid, Bad, Bim, Noxa, and Puma) serve to
promote activation of these multi-domain family members
upon an apoptotic insult. The main function of the anti-
apoptotic Bcl-2 family proteins, on the other hand, is to
prevent the release of apoptogenic factors. Interestingly,
the hypothesis that Bcl-2 family proteins can release
cytochrome c through pore formation was based on the
discovery that some of these proteins showed high struc-
tural similarity to the pore-forming domain of the diph-
theria toxin, which, as mentioned above, is known to form
pores in the endosomal membrane [46, 47]. Several years
later, we discovered that Bax could also permeabilize the
lysosomal membrane, and thereby promote cell death by
the release of lysosomal cathepsins to the cytosol [26].
Confocal and immuno-electron microscopy showed that
Bax translocated from the cytosol to the lysosomal mem-
brane upon staurosporine treatment of human fibroblasts.
Furthermore, recombinant Bax was inserted into the mem-
brane of isolated rat liver lysosomes and caused the release
of lysosomal constituents. These data provided the first
evidence that Bax is mechanistically involved in LMP and
are now supported by a growing number of publications
demonstrating involvement of multiple pro- and anti-
apoptotic Bcl-2 family proteins in the regulation of lyso-
somal membrane integrity.
Bax is activated and relocated to lysosomes in hepato-
cytes upon treatment with free fatty acids [48, 49], in
cholangiocarcinoma cells in response to tumor necrosis
factor-related apoptosis inducing ligand (TRAIL) [50], and
in ovarian cancer cells treated with etoposide [51]. In all
three cases, small interfering RNA- (siRNA)-mediated
downregulation of Bax prevented LMP, indicating a
mechanistic importance of Bax’s lysosomal location. Fur-
thermore, siRNA-mediated downregulation of Bim was
found to prevent TRAIL-induced LMP [50]. Bim was
activated upon TRAIL treatment and colocalized with Bax
in lysosomes, suggesting that it may trigger Bax-mediated
LMP. In another study, Bid, the most well-known Bax
activator, was found to be involved in tumor necrosis factor
(TNF)-a-induced lysosomal destabilization in hepatocytes
[52]. Upon TNF-a treatment, Bid was detected in lyso-
somes, and cathepsin B was released to the cytosol.
However, no such release was seen in Bid-/- cells. Even
though the involvement of Bax was not considered in this
study, it is tempting to speculate that LMP was caused by
Bid-mediated activation of Bax. In a recent report, BH3
domain peptides were found to permeabilize isolated
lysosomes in the presence of Bax [50]. Interestingly, Bak,
the other main pore-forming Bcl-2 family protein, also
localizes to lysosomes [48], but there are as yet no reports
of Bak-induced LMP. Conceivably, triggering of LMP
could be a general function of pro-apoptotic Bcl-2 proteins.
Similar to mitochondrial membrane permeabilization [53],
LMP-associated Bax activation seems to rely on different
BH3-only proteins depending on the death stimulus and
cell type. In addition to a direct effect of Bcl-2 proteins at
the lysosomal membrane, Bcl-2 family members may
regulate LMP at the mitochondrial level as engagement of
mitochondria can lead to increased lysosomal release via
positive feed-back. However, as release of cathepsins has
been observed in Bax/Bak double knockout cells there are
clearly additional mechanisms independent of Bax and Bak
that contribute to LMP [54].
p53
Permeabilization of the lysosomal membrane occurs in
p53-induced apoptosis [55], during which p53 itself
localizes to lysosomes and triggers LMP in a transcription-
independent manner [56]. It was proposed that p53 phos-
phorylated at Ser15 (p-p53Ser15) may be recruited to the
lysosomal membrane by a newly discovered protein called
Lysosome-associated apoptosis-inducing protein contain-
ing the pleckstrin homology and FYVE domains (LAPF).
This protein, which associates with lysosomes upon
induction of apoptosis, is essential for cell death induced
by TNF-a, ionizing irradiation, and the DNA-damaging
drugs 5-fluorouracil and oxaliplatin [56, 57]. Downregu-
lation of either p53 or LAPF prevented TNF-a-induced
LMP [56]. Interestingly, silencing of LAPF expression
abrogated lysosomal translocation of p-p53Ser15, whereas
silencing of p53 expression had no effect on lysosomal
translocation of LAPF, indicating that LAPF may trigger
LMP by acting as an adaptor protein for p-p53Ser15.
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Furthermore, p-p53Ser15 localizes to lysosomes in cultured
cortical neurons after exposure to the psychoactive ingre-
dient of marijuana, D9-tetrahydrocannabiol [58], or
b-amyloid [59], both of which cause neuronal cell death.
Also in these models of apoptosis, LMP was abrogated by
siRNA-mediated downregulation or chemical inhibition of
p53. It is worth noting that p53, under certain circum-
stances, localizes to the mitochondrial membrane during
apoptosis and can trigger mitochondrial membrane per-
meabilization by direct interaction with Bcl-2 family
members [60, 61]. It is tempting to speculate that a similar
mechanism governs p53-induced LMP. Additionally, p53
promotes Bax-mediated mitochondrial membrane perme-
abilization through transcriptional upregulation of the
BH3-only-domain proteins Puma and Noxa [62–64]. In this
way, p53 may engage the lysosomal pathway without
translocating to lysosomes. Recent data from our lab sup-
ports this notion; ultraviolet B- (UVB)-induced, p53-
dependent LMP is associated with an increase in Puma and
Noxa expression without the appearance of p53 at the
lysosomal membrane [65].
Proteases
Caspases
There are a number of publications suggesting that casp-
ases, under certain circumstances, are involved in the
release of apoptogenic factors from lysosomes [50, 52,
66–69]. Caspase-8, in particular, plays a significant role in
the engagement of the lysosomal death pathway following
death receptor activation [50, 52, 67–69]. Caspase-8 can
trigger the release of cathepsins from purified lysosomes,
and the effect was enhanced by the addition of a cytosolic
fraction [67], indicating that caspase-8-induced LMP is at
least partly mediated by activation of one or several
cytosolic substrates. Bid, which presumably would trigger
Bax-mediated LMP, has been presented as a possible
candidate [52]. In our hands, neither caspase-8 nor acti-
vated Bid alone permeabilized the membrane of isolated
lysosomes [26], suggesting that additional factors, such as
Bax or Bak, are indeed required. In another intriguing
study, caspase-8 cleaved and activated caspase-9 in an
apoptosome-independent fashion [68]. By using geneti-
cally modified mouse embryonic fibroblasts, caspase-9 was
proven to be indispensable for triggering LMP, but the
exact mode of action remains elusive. Interestingly,
depletion of Bid did not prevent the loss of lysosomal
membrane integrity. These data suggest that there are at
least two different mechanisms by which caspase-8 is able
to induce LMP.
In a recent study, caspase-2 activation was shown to be
required for LMP during endoplasmic reticulum stress-
induced apoptosis [70]. The effect was not dependent on
Bax, ceramide, Ca2?, or reactive oxygen species (ROS)
production, suggesting a more direct role of caspase-2.
Indeed, caspase-2 has previously been shown to induce
cathepsin release from purified lysosomes [67].
Cathepsins
It has been proposed that lysosomal proteases, in particular
cathepsin B, may contribute to their own release [31, 48,
71]. In mouse hepatocytes, lysosomal destabilization
evoked by TNF-a and sphingosine is dependent on
cathepsin B, as induction of LMP fails in cathepsin
B-deficient cells [31]. Moreover, chemical inhibition of
cathepsin B significantly reduces both free fatty acid- and
TRAIL-induced LMP [48, 71]. However, it is not clear
whether intra- or extralysosomal cathepsin B is involved.
As cathepsin B is constitutively active inside lysosomes, it
cannot be sufficient for LMP; however, it may be necessary.
Data in favor of intralysosomal cathepsin B as a mediator of
LMP was provided by cell-free experiments in which
sphingosine was found to cause lysosomal release from
cathepsin B-containing but not from cathepsin B-deficient
lysosomes [31]. Alternatively, cathepsin B-mediated LMP
may constitute an amplifying feedback loop, in which a
small amount of released cathepsin B triggers more exten-
sive LMP from outside the lysosome. The latter is supported
by the finding that upregulation of serine protease inhibitor
2A, a potent inhibitor of cathepsin B located in the cytosol
and nucleus, reduces lysosomal breakdown [72].
Calpains
Calpains catalyze lysosomal membrane destabilization
during neuronal cell death [73–76]. Cell death induced by
ischaemia or hypochloric acid is associated with an
increase in cytosolic [Ca2?], activation of calpains, and
LMP. Activated l-calpain localizes to the lysosomal
membrane prior to release of cathepsins, indicating
involvement in the triggering of LMP [74, 75, 77]. In
further support of this hypothesis, l-calpain can permea-
bilize the membrane of isolated lysosomes [67], and
pharmacological inhibition of calpains abrogates LMP
[73]. Interestingly, calpain activity correlates with the
appearance of p-p53Ser15 at the lysosomal membrane,
suggesting that calpains may, under certain circumstances,
promote p53-mediated lysosomal release [59].
Reactive oxygen species
An increased production of ROS may lead to destabiliza-
tion of the lysosomal membrane via massive peroxidation
of membrane lipids. Photosensitizers located in lysosomes
Apoptosis (2010) 15:527–540 531
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that generate singlet oxygen upon radiation have been shown
to cause rapid release of cathepsins to the cytosol [78–80].
Moreover, apoptosis induced by UVA radiation or H2O2,
both of which trigger cell death mainly by generating oxi-
dative stress, involves LMP [12, 65, 81]. Additionally, other
apoptosis inducers, e.g., N-(4-hydroxyphenyl)retinamide
[82] and vacuolar ATPase inhibitors [83], cause ROS-depen-
dent LMP. However, in the latter model systems it is not
clear whether leakage over the lysosomal membrane is due to
ROS-mediated membrane damage. Alternatively, altera-
tions in the intracellular redox balance may elicit a redox-
dependent signaling cascade resulting in LMP.
Induction of LMP by lysosomal membrane peroxidation
reactions has been extensively studied in model systems in
which the intralysosomal iron content has been manipu-
lated [84–88]. It is hypothesized that intralysosomal iron,
originating from degraded metallo proteins, reacts with
H2O2 and generates highly reactive hydroxyl radicals that
initiate peroxidation of the lysosomal membrane (Fig. 3).
In an illustrative experiment, macrophages that were
allowed to phagocytose silica particles with high amounts
of surface-bound iron suffered from extensive lysosomal
damage, while those that ingested silica particles pretreated
with the pharmacologic iron chelator desferrioxamine dis-
played only modest lysosomal leakage [89]. In several
additional studies it has been established that phagocytosis
of iron complexes or iron-containing proteins increases
lysosomal vulnerability, while a reduction in intralysoso-
mal reactive iron reduces lysosomal leakage and cell death
[84–88].
Kinases
Cellular signal transduction involves a wide range of small
GTPases and kinases constituting a complex signaling
network that ultimately regulates virtually all cellular
events including cell proliferation, differentiation, and cell
death. Ras signaling pathways participate in the overall
regulation of lysosomal function, and phosphatidylinositol-
3-kinase (PI3K), one of the downstream targets of Ras, is
indispensable for vesicular transport to lysosomes [90–92].
H-ras driven transformation of NIH3T3 cells causes
increased expression of cysteine cathepsins and reduced
lysosomal stability during TNF-induced cell death [93].
Inhibition of PI3K sensitizes vascular endothelial cells to
cytokine-induced apoptosis by increasing lysosomal per-
meability [94]. Furthermore, activation of c-Jun N-terminal
kinase (JNK) promotes lysosomal breakdown in response
to TNF-a, TRAIL, and UVB radiation, possibly via acti-
vation of the BH3-only-domain protein Bim [50, 95, 96].
Additionally, in neurons exposed to b-amyloid, phosphor-
ylation of p53 at Ser15 is JNK1 dependent [97]. In contrast,
inhibitors of JNK fail to affect lysosomal permeability in
H-ras transformed NIH3T3 cells. Instead, activation of the
Raf1-extracellular signal-regulated kinase (-ERK) pathway
is responsible for increased engagement of the lysosomal
death pathway [98]. Taken together, these data suggest that
LMP is likely regulated by kinase-dependent signaling
events, although the number of studies so far is limited.
Changes in lysosomal membrane lipid composition
Obviously, the lysosomal membrane composition plays a
key role in the maintenance of lysosomal integrity. Dam-
age to lysosomal membrane components or changes in the
membrane structure and fluidity could result in lysosomal
destabilization.
PLA2, phospholipase C, and sphingomyelinase,
enzymes that regulate the membrane lipid composition, all
show increased activity in the presence of high cytosolic
[Ca2?], which is characteristic of apoptosis. Studies using
isolated rat lysosomes have shown that these enzymes [99–
102] as well as the phospholipid products arachidonic acid
[103], lysophosphatidylcholine [104], and phosphatidic
acid [105], affect the osmotic sensitivity of lysosomes,
making them more susceptible to osmotic stress.
PLA2 stands out as a particularly interesting candidate
because it is involved in lysosomal membrane destabili-
zation in several different experimental systems [30, 76,
106–109]. For example, lysosomes are permeabilized in a
PLA2-dependent fashion in response to low concentrations
of H2O2 [106]. In this context, activation of PLA2 is
dependent on an early minor release of lysosomal contents
(suggesting an alternative mechanism for the initial
Oxidative stress
Delivery of iron- 
containing compounds
Degradation
Release of 
lysosomal constituents
Lipid peroxidation
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2+Fe 3+Fe
H O2 2 2+Fe 3+Fe+ HO• + OH  +-
+H
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Fig. 3 Destabilization of the lysosomal membrane by lipid peroxi-
dation. In response to oxidative stress, increased amounts of hydrogen
peroxide can diffuse into the lysosome. In the lysosomal lumen, the
acidic milieu and the presence of low-molecular-weight iron, derived
from degraded iron-containing proteins, promotes the reduction of
iron and the generation of hydroxyl radicals. The hydroxyl radicals
induce peroxidation of membrane lipids and thereby cause leakage of
lysosomal constituents into the cytosol
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release), and PLA2 engages in an amplifying feed-back
loop. Notably, incubation of PLA2 with rat liver lysosomes
results in leakage of lysosomal constituents.
Apoptosis-associated LMP may also be mediated by an
increase in the sphingolipid sphingosine [10, 31]. Ceramide
is produced from sphingomyelin upon activation of
sphingomyelinases (SMase) and is further processed into
sphingosine by ceramidase [110] (Fig. 4). It has been
proposed that sphingosine accumulates inside lysosomes,
where it permeabilizes the membrane in a detergent-like
fashion, resulting in cell death [10]. Under certain cir-
cumstances, sphingosine-induced LMP is dependent on
cathepsin B, as sphingosine fails to permeabilize lysosomes
from cathepsin B-/- hepatocytes [31]. These data also
present the possibility that sphingosine serves as a general
trigger of cathepsin B-mediated intralysosomal events
leading to LMP.
In a recent publication, proteins upregulated in lyso-
somes at the onset of apoptosis-associated LMP were
identified using a proteomic approach [111]. Interestingly,
two of these proteins, prosaposin and protein kinase Cd,
can lead to activation of the lysosomal enzyme acid SMase.
Protein kinase Cd activates acid SMase after translocating
from the cytosol to the lysosomal membrane [112], and
prosaposin is the precursor of four lysosomal sphingolipid
activator proteins (saposins A-D) that promote acid SMase-
mediated sphingomyelin degradation [113].
Other factors
b-Amyloid
Alzheimer’s disease is an age-related progressive neuro-
degenerative disease in which b-amyloid peptides are
thought to confer neurotoxicity. Accumulation of b-amy-
loid in lysosomes of cultured cells results in LMP-depen-
dent cell death [114, 115]. As b-amyloid is amphipathic
and forms micelle-like aggregates [116, 117], the toxicity
of b-amyloid could be mechanistically similar to that of
lysosomotropic detergents, which self-assemble into
micelles within lysosomes [118]. Alternatively, b-amyloid,
which, like some of the Bcl-2 family proteins, shows
structural similarities to pore-forming bacterial toxins, may
trigger lysosomal release by creating pores. Indeed, olig-
omeric b-amyloid can incorporate into artificial lipid
bilayers and form pore-like structures [119, 120].
Apolipoprotein E
Apolipoprotein E (apoE) is involved in lipid transport and
one of its three major isoforms, apoE4, is a known risk
factor for Alzheimer’s disease. ApoE4-transfected cells
are more susceptible to lysosomal leakage induced by
b-amyloid as compared to untransfected cells or cells
transfected with apoE3 [121]. This effect is dependent on a
low intralysosomal pH, as overexpression of apoE4 fails
to potentiate leakage from lysosomes neutralized with
bafilomycin or NH4Cl. Furthermore, at acidic pH, apoE4
binds more avidly to phospholipid bilayer vesicles and
potentiates b-amyloid-induced disruption to a greater
extent. It was suggested that, especially at a low pH, apoE4
is converted into a molten globule capable of binding and
altering membrane stability [122]. Thus, such apoE4-
mediated effects on membrane stability are likely restricted
to the lysosomal membrane, and may, under certain cir-
cumstances, play a significant role in the determination of
cell fate.
Aryl hydrocarbon receptor
In a murine hepatoma cell line in which TNF-a-induced
cell death was found to be independent of caspase-8, LMP
was dependent on the aryl hydrocarbon receptor (Ahr)
[123]. This receptor is a ligand-activated transcription
factor whose target genes are involved in many cellular
functions, including apoptosis. In addition, it has been
suggested that the Ahr may have ligand-independent
activities. Ahr deficiency prevents disruption of lysosomes
induced not only by TNF-a treatment, but also following
photodynamic therapy [124].
Sphingomyelin
Ceramide
Sphingosine
Lysosomal
membrane
permeabilization
Sphingomyelinase
Ceramidase
Sphingomyelin
synthase
Ceramide
synthase
Fig. 4 Accumulation of sphingosine leads to lysosomal membrane
permeabilization. An apoptotic stimulus, e.g., tumor necrosis factor-a,
leads to increased activity of sphingomyelinase, which catalyzes the
formation of ceramide from sphingomyelin. By the action of
ceramidase, ceramide is then converted into sphingosine, which
accumulates in lysosomes and acquires detergent-like properties,
leading to lysosomal membrane permeabilization
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ANT
The adenine nucleotide translocator (ANT) agonist atract-
yloside, which triggers opening of the mitochondrial per-
meability transition pore and release of mitochondrial
cytochrome c, was shown to also induce release of
cathepsin B from isolated lysosomes [125]. This was
accidentally discovered by researchers aiming to identify
factors released from a mitochondrial fraction, apparently
contaminated with lysosomes. This finding suggests that
ANT-like proteins may be present in the lysosomal mem-
brane and regulate its permeability; however, in our hands,
only a very high concentration of atractyloside permeabi-
lized the membrane of isolated rat liver lysosomes [26].
Granulysin
The killer effector molecule granulysin, which, together
with perforin and granzymes, is located in the cytolytic
granules of human cytotoxic T-lymphocytes and natural
killer cells was recently found to cause necroptosis (pro-
grammed necrosis) via LMP [19]. Granulysin, which
interacts with lipids to cause disruption of membranes, has
a broad-spectrum antimicrobial function and shows potent
cytotoxic activity against tumor cells. Granulysin enters
lysosomes of tumor cells and triggers release of cathepsin
B, which in turn engages the mitochondrial pathway via
cleavage of Bid. Thus, it appears that our immune system is
armed with a weapon to target lysosomes for the destruc-
tion of unwanted cells.
Safeguards of lysosomal membrane integrity
It has been suggested that the stability of the lysosomal
membrane could be modulated in different ways, and that
this could contribute to the determination of cell fate.
An example from normal physiological conditions is the
selection of B-lymphocytes in the germinal centers.
B-lymphocytes with high affinity B-cell receptors are
spared from apoptotic cell death by interaction with fol-
licular dendritic cells, which confer resistance to LMP [69].
The underlying mechanism was not unraveled in this study,
but molecules involved in the stabilization of the lysosomal
membrane have been identified by others (see below).
Furthermore, cancer cells often show various changes in
lysosomal function as well as altered susceptibility to
lysosome-mediated cell death. For example, activation of
the Ras or Src oncogenes is associated with changes in the
lysosomal distribution, density, size, ultrastructure, and
content, all of which may influence membrane stability [24,
90, 91, 98].
Heat shock proteins
Heat shock proteins (Hsps) are molecular chaperones
essential for cells’ ability to cope with environmental stress
[126]. Interestingly, Hsp70 is found at the lysosomes of
many tumor cells and stressed cells, and has been shown to
prevent LMP induced by TNF-a, etoposide, H2O2, or UVB
irradiation [27, 127, 128]. Notably, Hsp70 is frequently
overexpressed in tumors, and downregulation of Hsp70 in
breast, pancreatic, or colon cancer cells leads to LMP and
cathepsin-mediated cell death without any external death
stimuli [27, 129], suggesting that the tumorigenic potential
of Hsp70 could, in part, be due to stabilization of lyso-
somes. Hsp70 may prevent lysosomal membrane perme-
abilization by scavenging of lysosomal free iron and
blocking of oxidative events [128, 130]. Moreover, it is
tempting to speculate that Hsp70, which has been shown to
interact with Bax and prevent its translocation to mito-
chondria [131, 132], could interfere with Bax-induced
LMP.
In addition, Hsp70-2 can prevent permeabilization of the
lysosomal membrane [133]. In this case, the protective
effect depends on Hsp70-2-mediated upregulation of lens
epithelium-derived growth factor (LEDGF). Knockdown of
LEDGF in cancer cells induces destabilization of lyso-
somal membranes and cathepsin-mediated cell death, while
ectopic expression stabilizes lysosomes and prevents can-
cer cell death. However, as LEDGF has not been detected
in lysosomes, the protective mechanism remains obscure.
Bcl-2 proteins
Anti-apoptotic members of the Bcl-2 family are well-
known regulators of mitochondrial membrane permeabi-
lization, which, during recent years, have gained attention
as possible modulators of lysosomal membrane stability
[49, 50, 66, 134, 135]. Our finding that LMP may be
induced by Bax is supported by the fact that overex-
pression of Bcl-2 prevents lysosomal destabilization [66,
134, 135]. In two of these studies, it was suggested that
Bcl-2 stabilizes lysosomes by preventing activation of
PLA2 [134, 135]. However, it is tempting to speculate
that the protective effect of Bcl-2 is, at least in part, due
to neutralization of pro-apoptotic members of the Bcl-2
family. The theory that anti-apoptotic Bcl-2 proteins are
safeguards of lysosomal membrane integrity is supported
by data from Gregory Gores and co-workers [49, 50]. In
these studies, Mcl-1 and Bcl-XL prevented LMP induced
by TRAIL and free fatty acids, respectively. In both
cases, Bax was activated and translocated from the
cytosol to lysosomes upon apoptosis induction. Further-
more, overexpression of Mcl-1 and Bcl-XL, as well as
534 Apoptosis (2010) 15:527–540
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siRNA-mediated downregulation of Bax, stabilized the
lysosomal membrane.
Antioxidants
As described previously, ROS may compromise the
integrity of lysosomes via peroxidation of membrane lip-
ids. A variety of protective mechanisms have evolved to
scavenge ROS and protect cells from their adverse effects;
these are collectively known as the cell’s antioxidant
defense. The defense mechanisms include low-molecular-
weight antioxidants, for example vitamins C and E, coen-
zyme Q10, and glutathione, as well as antioxidant
enzymes, such as glutathione peroxidase, catalase, and
superoxide dismutase [136]. Vitamin E, a lipid soluble
antioxidant that protects from lipid peroxidation [137], can
prevent lysosomal release [5, 138]. Moreover, LMP
induced by N-(4-hydroxyphenyl) retinamide or inhibitors
of the vacuolar ATPase can be abrogated by increasing the
amount of intracellular cysteine, which alters the redox
balance [82, 83].
Furthermore, iron-binding proteins may serve to miti-
gate oxidant-induced LMP, as intralysosomal free iron can
generate highly reactive hydroxyl radicals, leading to per-
oxidation of membrane lipids. Indeed, a number of studies
have demonstrated that iron-binding proteins such as fer-
ritin and metallothionein can reduce lysosomal leakage and
cell death [84, 85, 139]. As mentioned above, also Hsp70
can bind intralysosomal redox-active iron and may, in that
way, protect the lysosomal membrane from free-radical
attack and permeabilization [128, 130].
Cholesterol and sphingomyelin
Cholesterol may play an important role in the maintenance
of lysosomal membrane stability. It has long been known
that addition of cholesterol to lysosomes reduces their
permeability [140]. Accordingly, a reduced lysosomal
membrane cholesterol level is associated with increased
permeability to protons and potassium ions; this, in turn,
causes an osmotic imbalance and destabilization of the
lysosomal membrane [141–143]. Sphingomyelin affects the
membrane fluidity by acting as a scaffold for incorporation
of cholesterol [144, 145]. Exogenous sphingomyelin, as
well as the sphingomyelin derivative 3-O-methylsphing-
omyelin, have been shown to accumulate in the lysosomal
membrane and protect from lysosomal membrane disrup-
tion in response to TNF-a and lysosomal photosensitizers
[78]. Thus, apoptosis-associated conversion of sphingo-
myelin into sphingosine (Fig. 4), a promoter of LMP,
appears to have a dual negative effect on lysosomal mem-
brane integrity.
Lysosome-associated membrane protein-1 and -2
The lysosomal membrane contains highly glycosylated
proteins whose complex intralumenal carbohydrate side
chains form a coat on the inner surface of the membrane. It
has been suggested that these glycoproteins serve as a
barrier against the hydrolytic activity of the lysosomal
enzymes and thereby prevent accidental release of lyso-
somal constituents into the cytosol. Lysosome-associated
membrane protein-1 (LAMP)-1 and -2, which constitute
*50% of the lysosomal membrane proteins [146, 147], can
modulate the sensitivity of the lysosomal membrane to an
apoptotic insult [98]. Oncogene-induced reduction in
LAMP-1 and -2 can be caused by cathepsin B overex-
pression and is associated with increased susceptibility to
LMP in response to photo-oxidation and the anti-cancer
drug siramesine. The authors of that finding speculate that
upregulation of lamp-1 and -2 mRNA, which has been
observed in various human cancers [148, 149], might be an
attempt to compensate for the deleterious effect of the
reduced half-life of LAMP-1 and -2 in cancer cells over-
expressing lysosomal cysteine cathepsins.
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Fig. 5 Factors regulating lysosomal membrane permeabilization.
This schematic presents a number of factors that may be responsible
for lysosomal membrane permeabilization (LMP). The relative
importance of each mechanism likely depends on the cell type and
death stimulus. Mechanisms that are believed to safeguard lysosomal
integrity and protect from lysosome-mediated cell death are also
shown. ‘‘Changes in membrane lipid composition’’ includes mem-
brane destabilizing factors such as phospholipase A2 and sphingosine,
as well as LPM protective substances e.g., cholesterol and sphingo-
myelin. Abbreviations: JNK, c-Jun N-terminal kinase; LAPF, lyso-
some-associated apoptosis-inducing protein containing the pleckstrin
homology and FYVE domains; Hsp, heat shock protein; ROS,
reactive oxygen species; ANT, adenine nucleotide translocator; Ahr,
aryl hydrocarbon receptor; LEDGF, lens epithelium-derived growth
factor; LAMP, lysosome-associated membrane protein
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Conclusion
A growing body of evidence suggests that apoptosis is
generally associated with LMP, occurring either as a trig-
gering early event or an amplifying late event. With the
wider acceptance of lysosomes as part of the signaling
cascade leading to apoptotic cell death, the molecular
mechanisms governing LMP have received increased
attention. As outlined above, there are many proteinaceous
and non-proteinaceous factors, including Bcl-2 family
proteins, ROS, caspases, cathepsins, cholesterol, and Hsps,
that influence the stability of the lysosomal membrane, and
their individual importance appears to depend on the cell
type and death stimulus (Fig. 5). However, the main
mechanism responsible for apoptosis-associated LMP, if
any, remains to be identified. A deeper understanding of
the regulation of LMP and other apoptosis signaling events
could enable the development of novel therapies for dis-
eases associated with excessive or insufficient apoptosis
such as neurodegenerative disorders and cancer,
respectively.
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